share_log

Short Interest in HAVN Life Sciences Inc. (OTCMKTS:HAVLF) Grows By 56.3%

Short Interest in HAVN Life Sciences Inc. (OTCMKTS:HAVLF) Grows By 56.3%

哈維生命科學公司(場外市場代碼:HAVLF)的空頭股數增長了56.3%
Financial News Live ·  2022/10/29 10:12

HAVN Life Sciences Inc. (OTCMKTS:HAVLF – Get Rating) was the recipient of a large growth in short interest during the month of October. As of October 15th, there was short interest totalling 2,500 shares, a growth of 56.3% from the September 30th total of 1,600 shares. Based on an average daily volume of 9,800 shares, the short-interest ratio is currently 0.3 days.

HAvn Life Science Inc.(場外市場代碼:HAVLF-GET Rating)是10月份空頭股數增長較快的公司。截至10月15日,空頭股數共有2500股,比9月30日的1600股增長了56.3%。以日均成交量9,800股計算,短息比率目前為0.3天。

HAVN Life Sciences Trading Up 39.4 %

HAVN生命科學公司股價上漲39.4%

HAVLF stock traded up $0.03 during trading on Friday, hitting $0.09. 3,415 shares of the stock traded hands, compared to its average volume of 4,465. HAVN Life Sciences has a one year low of $0.05 and a one year high of $6.66. The company has a 50 day simple moving average of $0.19 and a 200 day simple moving average of $0.92.

在週五的交易中,HAVLF的股票上漲了0.03美元,達到0.09美元。該股有3415股易手,而其平均成交量為4465股。HAvn Life Sciences的一年低點為0.05美元,一年高位為6.66美元。該公司的50日簡單移動均線切入位在0.19美元,200日簡單移動均線切入位在0.92美元。

Get
到達
HAVN Life Sciences
擁有生命科學學位
alerts:
警報:

HAVN Life Sciences Company Profile

HAVN生命科學公司簡介

(Get Rating)

(獲取評級)

HAVN Life Sciences Inc, a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp.
HAVN生命科學公司是一家生物技術公司,從事從植物和真菌中提取的精神藥理產品的研究和開發。該公司還專注於開發從植物和真菌(包括裸子菌屬)中標準化和質量控制地提取精神活性化合物的方法。

Featured Stories

專題報道

  • Get a free copy of the StockNews.com research report on HAVN Life Sciences (HAVLF)
  • McDonald's Stock Sizzles, but Will it Hit a New All-Time High?
  • Apple Inc. Stock Q4 Results Beat Negative Outlook, Stock Rises
  • Chevron Gushes More Profits; Is it Time for Investors to Buy?
  • Can Comcast Monetize Existing Users for Streaming Success?
  • Why is Amazon Stock Falling? Is the Sell-Off Overdone?
  • 免費獲取StockNews.com關於HAVN生命科學的研究報告(HAVLF)
  • 麥當勞股價下跌,但它會創下歷史新高嗎?
  • 蘋果。第四季度業績好於負面預期,股價上漲
  • 雪佛龍獲得更多利潤;投資者是時候買入了嗎?
  • 康卡斯特能否通過流媒體的成功將現有用户貨幣化?
  • 為什麼亞馬遜的股票會下跌?拋售是否過頭了?

Receive News & Ratings for HAVN Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HAVN Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

接受《HAVN生命科學日報》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對HAVN生命科學和相關公司的最新新聞和分析師評級的每日簡要摘要。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論